Category: Herbs & Ingredients
Ashwagandha has been flagged by reviewing bodies for a possible effect on blood sugar, which is why diabetes medicines sit on its interaction list. The evidence is limited and the concern is additive. This article sets out what to ask before combining them.
Category: Herbs and Ingredients | Reading time: ~11 min | Level: Intermediate
Ashwagandha is bought for calm and sleep, not for blood sugar. But if you manage diabetes with medication, the two questions overlap. A medicine whose job is to lower blood glucose, plus a botanical that some reviewing bodies think may also lower it, can in principle stack, and stacking two glucose-lowering effects is how a controlled number can drift into a low.
This is a quiet, additive concern rather than a dramatic clash, and the evidence sitting under it is limited. No landmark trial has put ashwagandha on top of metformin or insulin and measured the result. What exists is a formal caution from reviewing bodies and a plausible reason for it, and that is enough to make this a diabetes-team conversation rather than a casual purchase.
One thing to be clear about from the start. The interaction described here is drawn from the published literature and the NIH evidence reviews. It is not a claim manufactured by any single product or platform. The reviewing sources are named at the end so you can check them yourself.
Ashwagandha, botanical name Withania somnifera, is an adaptogen best known for stress and sleep. Reviewing bodies list diabetes and blood sugar medicines among the drug groups to be cautious with when using it, on the basis that ashwagandha may lower blood glucose [1]. That is the entire basis for the interaction: a drug designed to bring glucose down, combined with a botanical that may nudge it down as well, could together lower it more than the drug alone was dosed to do [1].
The key word again is may. This is an additive concern, meaning two effects stacking, not a documented event. It matters most with the diabetes medicines that can cause low blood sugar on their own, chiefly insulin and sulfonylureas, and less with metformin, which rarely does.
It helps to separate the reasonably established from the inferred.
Reasonably established is that ashwagandha calms the stress response. Meta-analyses of its use for stress and anxiety report a measurable effect, graded moderate rather than strong, with a dose response signal in a 2026 pooled analysis [1][2]. Because the stress hormone cortisol raises blood sugar, calming that system offers a loose theoretical route by which glucose might ease. That is mechanism, not proof.
Not established is the blood sugar effect itself. Reviewing bodies describe the direct evidence for ashwagandha and blood sugar as insufficient, meaning the research is too limited to say confidently whether, or how much, it moves glucose [1]. And no robust human trial has measured ashwagandha's effect in people already taking diabetes medication. So the honest grade for this specific interaction is limited and theoretical. The caution exists because reviewing bodies chose to flag a possible glucose-lowering action, not because a controlled study recorded dangerous lows [1].
Holding both sides honestly: the lack of a trial is not proof of safety, and a flagged possibility is not proof of harm. What remains is a reasonable precaution. If you take a medicine that lowers blood sugar, especially one that can cause hypos, introduce a botanical that may also lower it carefully and with closer testing, not silently.
Your specific setup changes how much this matters. This table is a guide to the conversation, not a replacement for your diabetes team's judgement.
| Your situation | How much the interaction matters | Sensible approach | |---|---|---| | On insulin | Highest. Insulin causes low blood sugar on its own, so an added downward effect is least forgiving | Diabetes-team input first; test more often; know your hypo treatment | | On a sulfonylurea (for example gliclazide) | High. These can cause hypos, so stacking matters | Prescriber input before starting; closer monitoring in the first weeks | | On metformin alone | Modest. Metformin rarely causes lows by itself | Worth a conversation; watch readings, but the risk is lower | | Diet-controlled diabetes or prediabetes, no glucose-lowering drug | Low for this specific issue | No drug to stack with; general ashwagandha cautions still apply | | Well controlled, tempted to self-reduce medication | High risk of the wrong kind | Never cut prescribed diabetes medicine against a supplement |
The pattern is consistent. The more your medication can drive glucose low on its own, the more a possible extra nudge matters, and the more monitoring the pairing deserves.
The practical takeaways are narrow, which is how a real but modest interaction should read.
Do not start ashwagandha on top of a diabetes medicine without telling the prescriber or team who manages your diabetes. That is the headline. A short message or pharmacist chat is usually enough to get a sensible answer for your regimen.
If a trial is agreed, test more often. A few baseline readings before you start and closer monitoring for two to three weeks after turns an invisible effect into a visible trend on your meter. If glucose drifts lower or lows appear, you have a before and after to show your team.
Learn and respect the signs of low blood sugar: shakiness, sweating, a racing heart, hunger, irritability, confusion. Carry fast-acting sugar if your medication can cause hypos, and treat lows promptly rather than pushing through.
Do not adjust your own diabetes medication against a supplement. If your readings change, that is a monitored decision for your prescriber, not a self-correction against a capsule.
And keep the interaction in proportion with ashwagandha's other cautions. It carries a recognised liver injury signal, is not recommended in pregnancy or breastfeeding, and interacts with several other drug groups [1][3]. Those belong in the same decision.
It is worth being precise about why this is an additive concern rather than a toxic one, because the framing changes what you actually do about it.
Ashwagandha is not thought to poison glucose control or to interfere with how a diabetes drug works chemically. The concern is simpler and more mechanical: two things gently lowering blood sugar can add up to more than one. In a person whose medication already sits right at the edge of causing a low, a small extra push can be the difference between in-range and hypo. In a person on metformin alone, which rarely causes lows, the same small push has far less room to cause trouble [1].
That is why the response is monitoring rather than avoidance for most people, and greater caution specifically for insulin and sulfonylureas. Precision dosing plus an unmeasured supplement is the mismatch, and blood sugar, tested daily by many people who live with diabetes, is one of the easier places to actually see it.
If you and your diabetes team agree a trial of ashwagandha is reasonable, it helps to know what sensible monitoring involves, because the interaction is invisible until it shows on a meter.
The most useful thing you can do is test more often in the first two to three weeks, at the times you are most likely to catch a low. For many people that means before meals and before bed, and around exercise, which itself lowers glucose. A short run of readings before you start gives you a baseline, and the same pattern after starting shows whether anything has moved. If you use a continuous glucose monitor, the trend arrows and overnight traces make a downward drift easier to see than fingersticks alone.
What you are watching for is glucose running lower than your usual pattern, or actual low readings, especially if you take insulin or a sulfonylurea. A single unexpected low is worth noting; a run of them is worth a call to your team before the next ashwagandha dose. The response is a medical decision about your medication, not a self-directed change to either the drug or the supplement.
It is also worth being honest that this is more monitoring than most stress supplements are worth. An ingredient that reviewing bodies flag for a possible glucose effect earns a measured approach, and if that feels like more effort than a calm-and-sleep supplement justifies for you, that is a perfectly reasonable conclusion. There are gentler options for stress that carry no blood sugar question at all, and choosing one of those is a legitimate outcome of this thinking rather than a failure to try hard enough.
The blood sugar question is the focus here, but ashwagandha carries other cautions that belong in the same decision. The US LiverTox database rates it a likely cause of clinically apparent liver injury, usually within weeks to a few months of starting and generally reversible on stopping, with rare severe cases [3]. Reviewing bodies also list cautions alongside thyroid medicines, blood pressure medicines, sedatives, seizure medicines and immune-suppressing drugs, and advise against use in pregnancy and breastfeeding [1].
Pregnant, breastfeeding, or on medication? Check with a healthcare professional first.
Ashwagandha earns its place in the Remedy Library for stress, where its evidence is moderate, and the blood sugar question is exactly why it should never be treated as a casual purchase for someone managing diabetes with medication. The Ashwagandha Stress Tonic is presented with its cautions attached rather than buried, because an interaction like this one is part of the honest picture of the ingredient. Structure and function only: ashwagandha supports the body's stress response. It is not a diabetes treatment, and it must not be used to self-manage blood sugar or to replace prescribed medication.
If you are unsure whether your medication list makes ashwagandha a poor fit, Remy, the PlantRx assistant, can surface the published cautions relevant to you before you decide, and point you back to your diabetes team for the calls only a glucose reading can settle.
1. National Center for Complementary and Integrative Health (NCCIH). Ashwagandha: Usefulness and Safety. Government evidence and safety review, which lists diabetes and blood sugar medicines among ashwagandha's interaction cautions and grades the direct blood sugar evidence as insufficient. nccih.nih.gov/health/ashwagandha. 2. Dose response meta-analysis of ashwagandha supplementation for stress and anxiety outcomes (2026), Complementary Therapies in Medicine, PMID 41644067. Cited for the stress-calming mechanism, not for a blood sugar claim. 3. National Institute of Diabetes and Digestive and Kidney Diseases, LiverTox. Ashwagandha (NBK548536). Government safety monograph, cited for the liver injury signal.
Not without checking with the prescriber or team who manages your diabetes first. Reviewing bodies list diabetes medicines among ashwagandha's interaction cautions because it may lower blood sugar, and stacking that on metformin could push your glucose lower than intended. Metformin alone rarely causes low blood sugar, so the concern is modest, but it is still worth a conversation and a plan to watch your readings in the first couple of weeks.
It may, but the direct evidence is thin. Reviewing bodies describe the blood sugar evidence for ashwagandha as insufficient, meaning there is not enough good research to say confidently how much, or how reliably, it moves glucose. That uncertainty is exactly why combining it with a medicine that is designed to lower blood sugar deserves a prescriber's input rather than a self-directed trial.
Insulin is the setting where the additive concern matters most, because insulin can cause low blood sugar on its own and a glucose-lowering botanical could add to that. This does not make the combination forbidden, but it does mean it should only happen with your diabetes team informed and your glucose monitored more closely, not discovered after a hypo. Know your low blood sugar symptoms and how to treat them.
Shakiness, sweating, a racing heart, hunger, irritability, confusion, difficulty concentrating, and in more severe cases drowsiness or loss of consciousness. If you take a medicine that can cause hypoglycaemia and you add ashwagandha, learn to recognise these early, carry fast-acting sugar, and tell your prescriber if episodes appear or become more frequent.
No. Never reduce or stop a prescribed diabetes medicine to make room for a supplement. Your treatment is dosed against your glucose readings and your overall risk, and ashwagandha is not a substitute for it. If your readings genuinely changed on ashwagandha, any dose adjustment is a decision for your prescriber, made against measured numbers, not a self-correction against a capsule.
If there is an effect, it is likely to build over days and weeks rather than after a single dose. That gradual profile is why the practical advice is to check glucose more often in the first two to three weeks of a trial, so any change appears as a trend on your meter rather than as a surprise hypo.
If you are not on any glucose-lowering medication, the additive interaction does not apply, because there is no drug to stack with. The general cautions for ashwagandha still do, including its liver signal and pregnancy advice. If you are monitoring blood sugar or considering it for metabolic reasons, treat that as a clinician conversation rather than a self-managed experiment.
Well controlled means your medication is holding your glucose in a target range, and a botanical that may lower blood sugar is one more variable in that balance. Even a short course is worth clearing with your diabetes team, ideally with a plan to test more often in the first fortnight. The cost of asking is a short conversation. The cost of not asking is an unexplained low or a lost sense of what your numbers mean.
That is not a decision to make from a supplement label, and there is no strong trial supporting ashwagandha as a way to cut prescribed treatment. If your glucose genuinely fell, a prescriber might review your doses, but that is a monitored medical decision against measured readings. Adjusting your own medication against a supplement is how people end up swinging between highs and lows.
Timing and testing separate them. A few days of baseline readings before you start, and closer testing for two to three weeks after, gives you a before and after. If glucose trends lower or lows appear in that window, ashwagandha is a reasonable suspect to raise with your team, who can weigh it against food, activity, illness and recent dose changes.